The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Public ClinicalTrials.gov record NCT04329728. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Phase 1/2 Study Evaluating Immunomodulatory AVM0703 in Patients With Lymphoid Malignancies (OPAL Study)
Study identification
- NCT ID
- NCT04329728
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- AVM Biotechnology Inc
- Industry
- Enrollment
- 144 participants
Conditions and interventions
Conditions
Interventions
- AVM0703 Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 95 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 5, 2020
- Primary completion
- Nov 29, 2027
- Completion
- Nov 30, 2028
- Last update posted
- Apr 14, 2026
2020 – 2028
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | Recruiting |
| Los Angeles Cancer Network | Los Angeles | California | 90017 | Recruiting |
| UCLA Medical Center of Hematology/Oncology | Los Angeles | California | 90095 | Recruiting |
| Innovative Clinical Research Institute | Whittier | California | 92705 | Recruiting |
| ASCLEPES Research Centers | Weeki Wachee | Florida | 34613 | Recruiting |
| University of Illinois at Chicago Cancer Center | Chicago | Illinois | 60612 | Recruiting |
| Norton Cancer Institute | Louisville | Kentucky | 40207 | Recruiting |
| Oncology Hematology West P.C. dba Nebraska Cancer Specialists | Omaha | Nebraska | 68124 | Recruiting |
| Gabrail Cancer Center Research, | Canton | Ohio | 44718 | Recruiting |
| Baptist Clinical Research Institute | Memphis | Tennessee | 38120 | Recruiting |
| University of Texas(UT) Southwestern-Children's Medical Center | Dallas | Texas | 75235 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04329728, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04329728 live on ClinicalTrials.gov.